XML 43 R6.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Cash flows from operating activities:      
Net loss $ (37,368,000)us-gaap_NetIncomeLoss $ (26,177,000)us-gaap_NetIncomeLoss $ (32,279,000)us-gaap_NetIncomeLoss
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 779,000us-gaap_DepreciationDepletionAndAmortization 1,630,000us-gaap_DepreciationDepletionAndAmortization 933,000us-gaap_DepreciationDepletionAndAmortization
Amortization of deferred financing costs and debt discount 1,220,000us-gaap_AmortizationOfFinancingCostsAndDiscounts 893,000us-gaap_AmortizationOfFinancingCostsAndDiscounts 930,000us-gaap_AmortizationOfFinancingCostsAndDiscounts
Joint Venture acquisition obligation accretion 579,000cytx_JointVentureAcquisitionObligationAccretion 204,000cytx_JointVentureAcquisitionObligationAccretion 0cytx_JointVentureAcquisitionObligationAccretion
Provision for doubtful accounts 1,084,000us-gaap_ProvisionForDoubtfulAccounts 1,141,000us-gaap_ProvisionForDoubtfulAccounts 144,000us-gaap_ProvisionForDoubtfulAccounts
Provision for Expired Enzyme 313,000cytx_ProvisionForExpiredEnzyme 0cytx_ProvisionForExpiredEnzyme 0cytx_ProvisionForExpiredEnzyme
Change in fair value of warrants (369,000)cytx_ChangeInFairValueOfWarrant (418,000)cytx_ChangeInFairValueOfWarrant (209,000)cytx_ChangeInFairValueOfWarrant
Change in fair value of option liability 0cytx_ChangeInFairValueOfOptions (2,250,000)cytx_ChangeInFairValueOfOptions 340,000cytx_ChangeInFairValueOfOptions
Stock-based compensation 3,101,000us-gaap_ShareBasedCompensation 3,608,000us-gaap_ShareBasedCompensation 3,904,000us-gaap_ShareBasedCompensation
Equity loss from investment in joint venture 0us-gaap_IncomeLossFromEquityMethodInvestments 48,000us-gaap_IncomeLossFromEquityMethodInvestments 165,000us-gaap_IncomeLossFromEquityMethodInvestments
Loss on asset disposal (33,000)us-gaap_GainLossOnSaleOfOtherAssets 257,000us-gaap_GainLossOnSaleOfOtherAssets 0us-gaap_GainLossOnSaleOfOtherAssets
Gain on previously held equity interest in joint venture 0us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain (4,892,000)us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain 0us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
Gain on sale of assets 0cytx_GainLossOnSaleOfProductLineAsset (4,453,000)cytx_GainLossOnSaleOfProductLineAsset 0cytx_GainLossOnSaleOfProductLineAsset
Loss on debt extinguishment 0us-gaap_ExtinguishmentOfDebtGainLossNetOfTax 708,000us-gaap_ExtinguishmentOfDebtGainLossNetOfTax 0us-gaap_ExtinguishmentOfDebtGainLossNetOfTax
Increases (decreases) in cash caused by changes in operating assets and liabilities:      
Accounts receivable 2,057,000us-gaap_IncreaseDecreaseInAccountsReceivable (1,209,000)us-gaap_IncreaseDecreaseInAccountsReceivable (1,810,000)us-gaap_IncreaseDecreaseInAccountsReceivable
Inventories (815,000)us-gaap_IncreaseDecreaseInInventories (459,000)us-gaap_IncreaseDecreaseInInventories 143,000us-gaap_IncreaseDecreaseInInventories
Other current assets 510,000us-gaap_IncreaseDecreaseInOtherCurrentAssets (24,000)us-gaap_IncreaseDecreaseInOtherCurrentAssets (324,000)us-gaap_IncreaseDecreaseInOtherCurrentAssets
Other assets 11,000us-gaap_IncreaseDecreaseInOtherNoncurrentAssets (854,000)us-gaap_IncreaseDecreaseInOtherNoncurrentAssets (74,000)us-gaap_IncreaseDecreaseInOtherNoncurrentAssets
Accounts payable and accrued expenses (1,147,000)us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities (409,000)us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities 1,183,000us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
Deferred revenues, related party 0cytx_IncreaseDecreaseDeferredRevenueRelatedParty (638,000)cytx_IncreaseDecreaseDeferredRevenueRelatedParty (2,882,000)cytx_IncreaseDecreaseDeferredRevenueRelatedParty
Deferred revenues (100,000)us-gaap_IncreaseDecreaseInDeferredRevenue (1,223,000)us-gaap_IncreaseDecreaseInDeferredRevenue (2,609,000)us-gaap_IncreaseDecreaseInDeferredRevenue
Long-term deferred rent (152,000)cytx_IncreaseDecreaseLongTermDeferredRentLiability (46,000)cytx_IncreaseDecreaseLongTermDeferredRentLiability 252,000cytx_IncreaseDecreaseLongTermDeferredRentLiability
Net cash used in operating activities (30,330,000)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations (34,563,000)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations (32,193,000)us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash flows from investing activities:      
Purchases of property and equipment (764,000)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (519,000)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (1,204,000)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Expenditures for intellectual property (255,000)us-gaap_PaymentsToAcquireIntangibleAssets 0us-gaap_PaymentsToAcquireIntangibleAssets 0us-gaap_PaymentsToAcquireIntangibleAssets
Proceeds from sale of assets 76,000us-gaap_ProceedsFromSaleOfProductiveAssets 5,000,000us-gaap_ProceedsFromSaleOfProductiveAssets 0us-gaap_ProceedsFromSaleOfProductiveAssets
License agreement termination fee (400,000)cytx_PaymentsForLicenseAgreementTerminationFee (800,000)cytx_PaymentsForLicenseAgreementTerminationFee 0cytx_PaymentsForLicenseAgreementTerminationFee
Cash acquired in purchase of the Joint Venture 0cytx_CashAcquiredInPurchaseOfJointVenture 5,000cytx_CashAcquiredInPurchaseOfJointVenture 0cytx_CashAcquiredInPurchaseOfJointVenture
Net cash provided by (used in) investing activities (1,343,000)us-gaap_NetCashProvidedByUsedInInvestingActivities 3,686,000us-gaap_NetCashProvidedByUsedInInvestingActivities (1,204,000)us-gaap_NetCashProvidedByUsedInInvestingActivities
Cash flows from financing activities:      
Principal payments on long-term obligations (1,962,000)us-gaap_RepaymentsOfLongTermDebt (22,304,000)us-gaap_RepaymentsOfLongTermDebt (2,692,000)us-gaap_RepaymentsOfLongTermDebt
Proceeds from long-term obligations 0us-gaap_ProceedsFromIssuanceOfLongTermDebt 27,000,000us-gaap_ProceedsFromIssuanceOfLongTermDebt 0us-gaap_ProceedsFromIssuanceOfLongTermDebt
Debt issuance costs and loan fees 0us-gaap_PaymentsOfFinancingCosts (1,744,000)us-gaap_PaymentsOfFinancingCosts 0us-gaap_PaymentsOfFinancingCosts
Joint venture purchase payments (2,262,000)us-gaap_PaymentsToAcquireInterestInJointVenture (221,000)us-gaap_PaymentsToAcquireInterestInJointVenture 0us-gaap_PaymentsToAcquireInterestInJointVenture
Proceeds from exercise of employee stock options and warrants and stock purchase plan 4,151,000us-gaap_ProceedsFromStockOptionsExercised 225,000us-gaap_ProceedsFromStockOptionsExercised 1,413,000us-gaap_ProceedsFromStockOptionsExercised
Proceeds from sale of common stock 19,001,000us-gaap_ProceedsFromIssuanceOfCommonStock 18,000,000us-gaap_ProceedsFromIssuanceOfCommonStock 24,953,000us-gaap_ProceedsFromIssuanceOfCommonStock
Proceeds from issuance of preferred stock 13,500,000us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock 0us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock 0us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
Costs from sale of common stock (425,000)us-gaap_PaymentsOfStockIssuanceCosts (184,000)us-gaap_PaymentsOfStockIssuanceCosts (1,482,000)us-gaap_PaymentsOfStockIssuanceCosts
Costs from sale of preferred stock (1,129,000)us-gaap_PaymentOfFinancingAndStockIssuanceCosts 0us-gaap_PaymentOfFinancingAndStockIssuanceCosts 0us-gaap_PaymentOfFinancingAndStockIssuanceCosts
Net cash provided by financing activities 30,874,000us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations 20,772,000us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations 22,192,000us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Effect of exchange rate changes on cash and cash equivalents (85,000)us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents (106,000)us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents 0us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents
Net decrease in cash and cash equivalents (884,000)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (10,211,000)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (11,205,000)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents at beginning of year 15,506,000us-gaap_CashAndCashEquivalentsAtCarryingValue 25,717,000us-gaap_CashAndCashEquivalentsAtCarryingValue 36,922,000us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents at end of year 14,622,000us-gaap_CashAndCashEquivalentsAtCarryingValue 15,506,000us-gaap_CashAndCashEquivalentsAtCarryingValue 25,717,000us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash paid during period for:      
Interest 2,588,000us-gaap_InterestPaid 2,252,000us-gaap_InterestPaid 2,497,000us-gaap_InterestPaid
Final payment fee on long-term debt 0cytx_FinalPaymentFeeOnLongTermDebt 1,078,000cytx_FinalPaymentFeeOnLongTermDebt 0cytx_FinalPaymentFeeOnLongTermDebt
Supplemental schedule of non-cash investing and financing activities:      
Conversion of preferred stock into common stock 16,000us-gaap_ConversionOfStockAmountConverted1 0us-gaap_ConversionOfStockAmountConverted1 0us-gaap_ConversionOfStockAmountConverted1
Declared dividend related to preferred stock 72,000us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1 0us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1 0us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1
Fair value of warrants allocated to additional paid-in capital 0cytx_FairValueOfWarrantsAllocatedToApic 949,000cytx_FairValueOfWarrantsAllocatedToApic 0cytx_FairValueOfWarrantsAllocatedToApic
Fair value of intangible assets acquired 0cytx_FairValueOfIntangibleAssetsAcquired 9,394,000cytx_FairValueOfIntangibleAssetsAcquired 0cytx_FairValueOfIntangibleAssetsAcquired
Fair value of tangible assets acquired 0cytx_FairValueOfTangibleAssetsAcquired 260,000cytx_FairValueOfTangibleAssetsAcquired 0cytx_FairValueOfTangibleAssetsAcquired
Joint venture purchase obligation 0cytx_FairValueOfJointVenturePurchaseObligation 4,709,000cytx_FairValueOfJointVenturePurchaseObligation 0cytx_FairValueOfJointVenturePurchaseObligation
Fair value of previously held equity interest at acquisition date $ 0cytx_FairValueOfPreviouslyHeldEquityInterestAtAcquisitionDate $ 4,928,000cytx_FairValueOfPreviouslyHeldEquityInterestAtAcquisitionDate $ 0cytx_FairValueOfPreviouslyHeldEquityInterestAtAcquisitionDate